Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full year ended December ...

Inogen reported total revenue of $81.7 million for the fourth quarter of 2025, a 2% increase compared to the same period last ...

(Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full year ended ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited ...

Inogen Inc. (INGN) on Tuesday reported a loss of $7.1 million in its fourth quarter. The Beverly, Massachusetts-based company said it had a loss of 26 ...

Noted a shift of large customer orders from Q4 2025 into the first half of 2026 due to customer capital and budgeting ...

“2024 was a very successful year for Inogen (INGN). We drove a return to revenue growth, improved profitability and disciplined cost management. Achievements in the quarter included the launch of Rove ...

Inogen Inc ( (INGN)) has released its Q3 earnings. Here is a breakdown of the information Inogen Inc presented to its investors. Inogen, Inc. is a global medical technology company specializing in ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, ...